Skip to main content

and
  1. Article

    Open Access

    Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study

    Older individuals often have a reduced immune response to influenza vaccination, which might be improved by administering a higher vaccine dose. We compared the immune response to two single doses of the AS03A-ad...

    Paul Gillard, Didier Giet, Stéphane Heijmans, Mamadou Dramé, Karl Walravens in Trials (2014)